Drugs Made In America Acquisition (DMIIR) Cash from Operations (2025)

Drugs Made In America Acquisition's (DMIIR) quarterly Cash from Operations came in at 314864.0 in Q4 2025.

Drugs Made In America Acquisition (DMIIR) Cash from Operations (2025) Analysis & Trends

Drugs Made In America Acquisition (DMIIR) has 1 years of Cash from Operations data on file, last reported at 314864.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 EQV Ventures Acquisition 480.75 Mn 480.75 Mn - -121,028.00
2 Agriculture & Natural Solutions Acquisition 393.29 Mn 393.29 Mn - 1.32 Mn
3 Berto Acquisition 314.56 Mn 314.35 Mn - -119,667.00
4 GP-Act III Acquisition 313.66 Mn 313.66 Mn - 10,832.00
5 Centurion Acquisition 311.65 Mn 311.65 Mn - -72,157.00
6 Republic Digital Acquisition 310.50 Mn 309.63 Mn - -147,921.00
7 Siddhi Acquisition Corp (Cayman Islands) 288.97 Mn 288.97 Mn - -207,911.00
8 K&F Growth Acquisition 283.42 Mn 283.42 Mn - -133,997.00
9 Bold Eagle Acquisition 275.29 Mn 275.29 Mn - -171,240.00
10 Drugs Made In America Acquisition - - - -314,864.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -314,864.00
Dec 31, 2025 -314,864.00